54 related articles for article (PubMed ID: 2575000)
1. Analysis of the PvuII and XbaI polymorphisms in the estrogen receptor alpha gene in girls with central precocious puberty: a pilot study.
Soares-Jr JM; de Holanda FS; Matsuzaki CN; Sorpreso ICE; de Arruda Veiga EC; de Abreu LC; Carvalho KC; Baracat EC
BMC Med Genet; 2018 May; 19(1):84. PubMed ID: 29801469
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle dependent oscillatory expression of estrogen receptor-α links Pol II elongation to neoplastic transformation.
Vantaggiato C; Tocchetti M; Cappelletti V; Gurtner A; Villa A; Daidone MG; Piaggio G; Maggi A; Ciana P
Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9561-6. PubMed ID: 24979764
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of EGFR (142285G>A) and ESR1 (2014G>A) gene polymorphisms and risk of breast cancer.
Sobti RC; Askari M; Nikbakht M; Singh N; Sharma SC; Abitew AM
Mol Cell Biochem; 2012 Oct; 369(1-2):217-25. PubMed ID: 22810499
[TBL] [Abstract][Full Text] [Related]
4. PvuII polymorphism of estrogen receptor-α gene in breast cancer.
Surekha D; Vishnupriya S; Rao DN; Sailaja K; Raghunadharao D
Indian J Hum Genet; 2007 Sep; 13(3):97-101. PubMed ID: 21957356
[TBL] [Abstract][Full Text] [Related]
5. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.
Crandall CJ; Sehl ME; Crawford SL; Gold EB; Habel LA; Butler LM; Sowers MR; Greendale GA; Sinsheimer JS
Breast Cancer Res; 2009; 11(4):R51. PubMed ID: 19630952
[TBL] [Abstract][Full Text] [Related]
6. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
Hu Z; Song CG; Lu JS; Luo JM; Shen ZZ; Huang W; Shao ZM
J Cancer Res Clin Oncol; 2007 Dec; 133(12):969-78. PubMed ID: 17562079
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study.
Wedrén S; Lovmar L; Humphreys K; Magnusson C; Melhus H; Syvänen AC; Kindmark A; Landegren U; Fermér ML; Stiger F; Persson I; Baron J; Weiderpass E
Breast Cancer Res; 2004; 6(4):R437-49. PubMed ID: 15217512
[TBL] [Abstract][Full Text] [Related]
8. The loss of estrogen and progesterone receptor gene expression in human breast cancer.
Lapidus RG; Nass SJ; Davidson NE
J Mammary Gland Biol Neoplasia; 1998 Jan; 3(1):85-94. PubMed ID: 10819507
[TBL] [Abstract][Full Text] [Related]
9. A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers.
Tang Z; Treilleux I; Brown M
Mol Cell Biol; 1997 Mar; 17(3):1274-80. PubMed ID: 9032254
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the origin of variant, truncated estrogen receptor-like mRNAs identified in some human breast cancer biopsy samples.
Murphy LC; Dotzlaw H; Hamerton J; Schwarz J
Breast Cancer Res Treat; 1993; 26(2):149-61. PubMed ID: 8219252
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of hormone resistance in breast cancer.
Horwitz KB
Breast Cancer Res Treat; 1993; 26(2):119-30. PubMed ID: 8219249
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility.
Andersen TI; Heimdal KR; Skrede M; Tveit K; Berg K; Børresen AL
Hum Genet; 1994 Dec; 94(6):665-70. PubMed ID: 7989041
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood.
Yaich L; Dupont WD; Cavener DR; Parl FF
Cancer Res; 1992 Jan; 52(1):77-83. PubMed ID: 1345763
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism.
Hill SM; Fuqua SA; Chamness GC; Greene GL; McGuire WL
Cancer Res; 1989 Jan; 49(1):145-8. PubMed ID: 2562795
[TBL] [Abstract][Full Text] [Related]
15. Somatic change in the estrogen receptor gene associated with altered expression of the progesterone receptor.
Wanless C; Barker S; Puddefoot JR; Panahy C; Goode AW; Vinson GP; Phillips IR
Anticancer Res; 1991; 11(1):139-42. PubMed ID: 2018347
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry.
Helin HJ; Helle MJ; Kallioniemi OP; Isola JJ
Cancer; 1989 May; 63(9):1761-7. PubMed ID: 2649227
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of the genetic risk in breast cancer.
Lidereau R
Eur J Gynaecol Oncol; 1989; 10(3):182-4. PubMed ID: 2567238
[No Abstract] [Full Text] [Related]
18. Genomic DNA analysis of the estrogen receptor gene in breast cancer.
Parl FF; Cavener DR; Dupont WD
Breast Cancer Res Treat; 1989 Oct; 14(1):57-64. PubMed ID: 2575000
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
